Aktis Oncology, Inc. ($AKTS)
Filing Information
| Accession Number | 0001231919-26-000057 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
43,418,355
Total Value
$20,029,986.00
P&L
+8.3% (+$1,669,165.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Jan 12, 2026 | Conversion | 1,314,262 | โ | โ | 1,655,971 | Indirect | See Footnote | View Details | |
10% Owner | Common Stock | โ | Jan 12, 2026 | Conversion | 5,914,197 | โ | โ | 7,570,168 | Indirect | See Footnote | View Details | |
10% Owner | Common Stock | โ | Jan 12, 2026 | Conversion | 1,577,119 | โ | โ | 9,147,287 | Indirect | See Footnote | View Details | |
10% Owner | Common Stock | โ | Jan 12, 2026 | Purchase | 1,112,777 | $18.00 | $20,029,986.00 | 10,260,064 | Indirect | See Footnote | View Details | |
10% Owner | Series Seed Redeemable Convertible Preferred Stock | Derivative | Jan 12, 2026 | Conversion | 5,000,000 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details | |
10% Owner | Series A Redeemable Convertible Preferred Stock | Derivative | Jan 12, 2026 | Conversion | 22,500,000 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details | |
10% Owner | Series B Redeemable Convertible Preferred Stock | Derivative | Jan 12, 2026 | Conversion | 6,000,000 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details |